Clinical Trial

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Study acronym: ANZ UGI
Recruiting
View on ClinicalTrials.gov →
Summary
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-26; most recent amendment 2025-03-25.
Trial Details
NCT Number NCT05804331
Lead Sponsor Western Sydney Local Health District
Conditions Cancer of Stomach, Oesophageal Cancer, Gastric Cancer, Gastric Adenocarcinoma, GI Cancer, GIST, Neuroendocrine Tumors, Gastric Neoplasm +1 more
Enrollment 500 participants
Start Date 2023-03-14
Primary Completion 2028-03-14 (estimated)
Study Completion 2028-09-14 (estimated)
Updated on ClinicalTrials.gov 2025-03-27